Lee et al showed that type I IFN signaling is important for maintaining Foxp3 expression in the inflamed mucosa in a model of T cell–mediated colitis and that the administration of recombinant IFNA ameliorates the severity of colitis by increasing the number of Foxp3 cells and by improving their function37. The gene discussed is IFNA1; the disease is colitis.